Lee, Amanda J.; Feng, Emily; Chew, ? et al.
Type I interferon regulates proteolysis by macrophages to prevent immunopathology following viral infectionPLOS PATHOGENS. Bd. 18. H. 5. 2022
Felber, Jorg; Blaker, Hendrik; Fischbach, Wolfgang et al.
Updated S2k guidelines for celiac disease from the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) December 2021-AWMF registration number: 021-021ZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 60. H. 05. 2022 S. 790-856
Schuppan, D
: Can Plant Materials Be Valuable in the Treatment of Periodontal Diseases?Pharmaceutics. Bd. 13. 2021 S. 2185
Reichardt, Marius; Jensen, Patrick Moller; Dahl, Vedrana Andersen et al.
3D virtual histopathology of cardiac tissue from Covid-19 patients based on phase-contrast X-ray tomographyELIFE. Bd. 10. 2021
Luhmann, Heiko J.; Sinning, Anne
A comment on "The growth of cognition: Free energy minimization and the embryogenesis of cortical computation"PHYSICS OF LIFE REVIEWS. Bd. 36. 2021 S. 71-73
Herzog, David P.; Cuadrado, Diego Pascual; Treccani, Giulia et al.
A distinct transcriptional signature of antidepressant response in hippocampal dentate gyrus granule cellsTRANSLATIONAL PSYCHIATRY. Bd. 11. H. 1. 2021
Crouchet, Emilie; Bandiera, Simonetta; Fujiwara, Naoto et al.
A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discoveryNATURE COMMUNICATIONS. Bd. 12. H. 1. 2021
Villesen, Ida; Langholm, Lasse; Leeming, Diana et al.
A novel liver-specific fibrosis biomarker, PRO-C18L, can predict response to antifibrotic treatment, with a peroxisome proliferator activated receptor -y agonist, in patients with chronic hepatitis CJOURNAL OF HEPATOLOGY. Bd. 75. 2021 S. S633-S633
Schuppan, Detlef; Maki, Markku; Lundin, Knut E. A. et al.
A randomized trial of a transglutaminase 2 inhibitor for celiac diseaseNEW ENGLAND JOURNAL OF MEDICINE. Bd. 385. H. 1. 2021 S. 35-45
Schuppan, D
A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosisJ Hepatology. 2021 S. 816